Norplant and contraceptive pricing :
conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.
|Corporate Author:||United States.|
Washington : U.S. G.P.O. : 1994-
Research and development partnership
Research and development partnership /
Research and development contracts, Government > Research and development contracts, Government / United States.
Drug development > Drug development / United States.
Contraceptives > Contraceptives / Prices > Contraceptives / Prices / United States.
Norgestrel > Norgestrel / Prices > Norgestrel / Prices / United States.
"Serial no. 103-59"--Pt. 3.
"Washington, DC, November 10, 1993"--Pt. 3.
Shipping list no.: 94-0103-P (pt. 3).
Distributed to some depository libraries in microfiche.
Description based on pt. 3.
ill., map ;
|Locate a Print Version:||
Find in a library
|Item Link||Original Source|
|Full view pt.3||Purdue University|
|Full view 4.SM 1:103-59||Pennsylvania State University|